Yasuko Uchigata Selected Research

Insulin Antibodies

3/2022	Recurrent Hypoglycemia Due to a High Titer of Insulin Antibody in Response to Exogenous Insulin Administration in Two Cases of Type 1 Diabetes.
1/2015	Severe Insulin-resistant Diabetes due to Insulin Antibodies Associated with Eosinophilia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuko Uchigata Research Topics

Disease

37	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022 - 02/2002
20	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2007
10	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2021 - 06/2003
9	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 02/2002
7	Albuminuria 05/2018 - 12/2011
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 05/2004
4	Chronic Renal Insufficiency 11/2021 - 05/2013
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2020 - 04/2004
4	Disease Progression 01/2019 - 10/2003
4	Diabetes Mellitus 04/2018 - 03/2014
4	Wounds and Injuries (Trauma) 06/2017 - 04/2015
4	Ketosis 08/2016 - 04/2004
3	Diabetic Angiopathies (Diabetic Angiopathy) 04/2018 - 01/2004
3	Diabetes Complications 01/2018 - 01/2004
3	Ulcer 01/2017 - 04/2015
3	Insulinoma 10/2012 - 07/2008
2	Hypoglycemia (Reactive Hypoglycemia) 03/2022 - 07/2015
2	Vitreous Hemorrhage 11/2021 - 05/2020
2	Body Weight (Weight, Body) 01/2020 - 01/2019
2	Osteoporosis 01/2018 - 11/2015
2	Hyperglycemia 08/2017 - 09/2016
2	Kidney Diseases (Kidney Disease) 04/2017 - 03/2014
2	Fatty Liver 03/2017 - 01/2008
2	Insulin Resistance 12/2016 - 01/2015
2	Obesity 08/2015 - 03/2014
1	COVID-19 07/2022
1	Infections 07/2022
1	Neovascular Glaucoma 11/2021
1	Hematuria 02/2021
1	Atherosclerosis 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Hypercholesterolemia 01/2018
1	Macular Edema 04/2017
1	Hepatomegaly 03/2017
1	Weight Loss (Weight Reduction) 02/2017
1	Collagen Diseases (Collagen Disease) 01/2017
1	Burns 01/2017
1	Peripheral Arterial Disease 01/2017

Drug/Important Bio-Agent (IBA)

22	Insulin (Novolin)FDA Link 03/2022 - 09/2002
7	AutoantibodiesIBA 01/2016 - 08/2003
5	Biomarkers (Surrogate Marker)IBA 04/2018 - 08/2006
4	HLA Antigens (Human Leukocyte Antigens)IBA 03/2020 - 06/2003
4	C-PeptideIBA 03/2020 - 01/2010
4	EnzymesIBA 10/2018 - 01/2003
4	Advanced Glycation End ProductsIBA 04/2018 - 01/2003
4	Glucose (Dextrose)FDA LinkGeneric 09/2016 - 07/2012
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019 - 12/2012
3	Blood Glucose (Blood Sugar)IBA 01/2019 - 08/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2015
3	CreatinineIBA 12/2017 - 05/2013
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2017 - 11/2005
3	Transaminases (Aminotransferases)IBA 03/2017 - 04/2004
3	Hypoglycemic Agents (Hypoglycemics)IBA 08/2016 - 09/2007
3	HLA-DR Antigens (HLA-DR)IBA 09/2011 - 02/2002
2	Insulin AntibodiesIBA 03/2022 - 01/2015
2	oxidized low density lipoproteinIBA 01/2019 - 01/2018
2	HDL CholesterolIBA 01/2019 - 04/2015
2	LipidsIBA 01/2019 - 01/2019
2	LDL CholesterolIBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2018 - 12/2017
2	Receptor for Advanced Glycation End ProductsIBA 12/2017 - 01/2007
2	Antihypertensive Agents (Antihypertensives)IBA 09/2016 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2012
2	LeptinIBA 03/2014 - 12/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2013 - 02/2002
2	Messenger RNA (mRNA)IBA 07/2012 - 01/2004
2	Zinc Transporter 8IBA 11/2011 - 02/2011
2	pentosidineIBA 01/2007 - 01/2003
1	casirivimab and imdevimab drug combinationIBA 07/2022
1	Combined Antibody TherapeuticsIBA 07/2022
1	dapagliflozinIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	HLA-DRB1*04:05 antigenIBA 10/2018
1	GlyceraldehydeIBA 04/2018
1	alfacalcidolIBA 01/2018
1	Parathyroid Hormone (Parathormone)IBA 01/2018
1	hydroxide ionIBA 01/2018
1	ProcollagenIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	CollagenIBA 01/2018
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2018
1	25-hydroxyvitamin DIBA 01/2018
1	Retinal Pigments (Pigments, Visual)IBA 04/2017
1	Hemoglobins (Hemoglobin)IBA 03/2017
1	HLA-DRB1*04 antigenIBA 02/2017
1	SteroidsIBA 01/2017

Therapy/Procedure

17	Therapeutics 05/2020 - 10/2003
8	Renal Dialysis (Hemodialysis) 11/2021 - 01/2003
7	Glycemic Control 03/2017 - 01/2009
4	Light Coagulation 05/2020 - 01/2017
4	Kidney Transplantation 08/2017 - 07/2015
4	Transplantation 06/2017 - 07/2015
3	Vitrectomy 11/2021 - 12/2017
2	Artificial Skin 01/2017 - 08/2015
2	Surgical Amputation (Amputations) 08/2015 - 04/2015
1	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2021
1	Peritoneal Dialysis 05/2020
1	Lasers (Laser) 05/2018
1	Cell Transplantation 01/2017